Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

31/01/2023 03:00

Jan 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              339.02              271.43           440.00    
                   (+24.9 pct)         (+15.5 pct)      (+21.8 pct) 
  Operating          122.59               82.17           149.00    
                   (+49.2 pct)         (+0.0 pct)       (+44.4 pct) 
  Pretax             124.38               84.35           150.00    
                   (+47.5 pct)         (-0.4 pct)       (+42.8 pct) 
  Net                 95.66               64.62           114.00    
                   (+48.0 pct)         (-2.8 pct)       (+41.6 pct) 
  EPS Basic        195.90 yen          129.61 yen       233.47 yen  
  EPS Diluted      195.88 yen          129.59 yen                   
  Ann Div                               56.00 yen        66.00 yen  
  -Q2 Div           33.00 yen           28.00 yen                   
  -Q4 Div                               28.00 yen        33.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T